Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blackfynn built a HIPAA-compliant cloud platform to integrate and analyze multimodal neuroscience and clinical data, and used this platform to support development of disease‑modifying therapeutic devices, drugs and clinical services in neurology; it pursued options to acquire late‑stage assets (including a Phase 3–ready Parkinson’s drug) but is best characterized as a data/platform company rather than a traditional clinical pipeline biotech.[2][3][5][9][10]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blackfynn.